The incidence and risk factors of hypofibrinogenemia in cardiovascular surgery.


Journal

General thoracic and cardiovascular surgery
ISSN: 1863-6713
Titre abrégé: Gen Thorac Cardiovasc Surg
Pays: Japan
ID NLM: 101303952

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 16 03 2019
accepted: 04 09 2019
pubmed: 19 9 2019
medline: 6 10 2020
entrez: 19 9 2019
Statut: ppublish

Résumé

Cardiovascular surgery often causes massive bleeding due to coagulopathy, with hypofibrinogenemia being a major causative factor. We assessed the intraoperative incidence of hypofibrinogenemia and explored predictors of hypofibrinogenemia. The intraoperative serum fibrinogen level (SFL) was routinely measured in 872 consecutive patients [mean age: 66.9 ± 13.3 years; 598 men (68.6%)] undergoing cardiovascular surgery from July 2013 to November 2016 at Nagoya University Hospital. There were 275 aortic surgeries, 200 cases of coronary artery bypass grafting (CABG), 334 valvular surgeries and 63 other surgeries. We estimated hypofibrinogenemia incidence (intraoperative lowest SFL ≤ 150 mg/dL) and identified its predictors by a logistic regression analysis. The average intraoperative lowest SFL of all cases, aortic surgery, CABG and valvular surgery was 185 ± 71, 156 ± 65, 198 ± 69 and 198 ± 68 mg/dL, respectively. Aortic surgery had a significantly lower intraoperative lowest SFL than CABG (p < 0.001) and valvular surgery (p < 0.001). The incidence of hypofibrinogenemia was 32.8%, 50.2%, 26.5% and 22.8% in all cases, aortic surgery, CABG and valvular surgery, respectively. The predictors of hypofibrinogenemia were the preoperative SFL, re-do surgery and perfusion time. A receiver operating characteristics curve analysis showed that the best preoperative SFL cutoff value for predicting hypofibrinogenemia was 308.5 mg/dL. Assuming preoperative SFL 300 mg/dL as the cutoff, the odds ratio for hypofibrinogenemia was 7.22 (95% confidence interval 5.26-9.92, p < 0.001). The incidence of hypofibrinogenemia in aortic surgery was high. The preoperative SFL, re-do surgery and perfusion time were identified as predictors for hypofibrinogenemia. Intraoperative measurement of SFL is important for detecting hypofibrinogenemia and applying appropriate and prompt transfusion treatment.

Identifiants

pubmed: 31531835
doi: 10.1007/s11748-019-01201-8
pii: 10.1007/s11748-019-01201-8
doi:

Substances chimiques

Fibrinogen 9001-32-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

335-341

Références

J Thorac Cardiovasc Surg. 2009 Sep;138(3):694-702
pubmed: 19698858
Ann Thorac Cardiovasc Surg. 2019 Jun 20;25(3):142-148
pubmed: 30568075
Thromb Haemost. 2015 Apr;113(4):759-71
pubmed: 25502954
Transfusion. 2009 Sep;49(9):2006-7; author reply 2007-8
pubmed: 19735504
Immunohematology. 2011;27(4):151-3
pubmed: 22646071
J Thorac Cardiovasc Surg. 2013 Mar;145(3 Suppl):S178-85
pubmed: 23410777
Transfusion. 2014 May;54(5):1389-405; quiz 1388
pubmed: 24117955
J Thorac Cardiovasc Surg. 2014 Oct;148(4):1647-55
pubmed: 24951020
Ann Thorac Surg. 2014 Apr;97(4):1199-206
pubmed: 24507940
Nagoya J Med Sci. 2015 Feb;77(1-2):265-73
pubmed: 25797992
Anesthesiology. 2013 Jan;118(1):40-50
pubmed: 23249928
Clin Appl Thromb Hemost. 2018 Sep;24(6):998-1004
pubmed: 29050500
Transfusion. 2014 Jan;54(1):109-18
pubmed: 23718572
Clin Appl Thromb Hemost. 2011 Aug;17(4):396-404
pubmed: 20530054
Br J Anaesth. 2009 Jun;102(6):785-92
pubmed: 19411671
Anaesth Intensive Care. 2000 Aug;28(4):420-6
pubmed: 10969370
Anesth Analg. 2018 Feb;126(2):425-434
pubmed: 28682954
Br J Anaesth. 2013 Jun;110(6):947-56
pubmed: 23388508
Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):292-8
pubmed: 24316606
J Cardiothorac Surg. 2014 May 19;9:90
pubmed: 24884627
Transfusion. 2008 Oct;48(10):2152-8
pubmed: 18657083
J Cardiothorac Vasc Anesth. 1997 Dec;11(7):824-7
pubmed: 9412877
J Cardiothorac Vasc Anesth. 2016 Oct;30(5):1196-204
pubmed: 27493092

Auteurs

Toshihiko Nishi (T)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8650, Aichi, Japan. t-nishi@med.nagoya-u.ac.jp.

Masato Mutsuga (M)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8650, Aichi, Japan.

Toshiaki Akita (T)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8650, Aichi, Japan.

Yuji Narita (Y)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8650, Aichi, Japan.

Kazuro Fujimoto (K)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8650, Aichi, Japan.

Yoshiyuki Tokuda (Y)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8650, Aichi, Japan.

Sachie Terazawa (S)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8650, Aichi, Japan.

Hideki Ito (H)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8650, Aichi, Japan.

Kimitoshi Nishiwaki (K)

Department of Anesthesiology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8650, Aichi, Japan.

Akihiko Usui (A)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8650, Aichi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH